Background and Goal of Study
Peritoneal carcinomatosis leads to a high mortality. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has improved the prognosis of these patients, however it is a major surgery with multiple complications. Our objective is to evaluate the survival and morbidity of patients operated in our center.

Materials and Methods
Retrospective observational study carried out in Clínica Universidad de Navarra. We performed a descriptive analysis of a total of 36 patients undergoing cytoreduction surgery with intraperitoneal hypertensive
chemotherapy from October 2012 to May 2017.

Results and Discussion
36 patients were analyzed; 61% 58 years old males.
Colon cancer was the first cause of surgery (58.3%). Surgical time average was 529 min (SD 125).
The main complications associated with CRS with HIPEC are mainly related to lung damage associated with inflammatory leakage, hyperdynamic haemodynamic alterations, multifactorial renal damage, and infectious complications as a lower rate.

05 / Multimodal approach of the patient operated on for peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Is it possible to improve survival?